Vaxxinity Other Current Assets

The latest other current assets for VAXX is $2.3M as of December 2023. That compares with $520K in the prior-year period — up 343.7% year over year. Investors often review this figure alongside Vaxxinity's historical trend and sector peers before judging valuation or financial health.

Over the past year, VAXX's other current assets moved from $520K to $2.3M — a 343.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vaxxinity's operating scale or balance-sheet position.

A other current assets figure of $2.3M for VAXX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VAXX's other current assets ($2.3M), review year-over-year change from $520K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.